Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine
Jul. 20, 2022—In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines
Jan. 24, 2022—Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.
Oct. 7, 2021—VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week's Boosta-Palooza event.
Vanderbilt University Medical Center begins giving COVID-19 vaccines to front-line caregivers
Dec. 17, 2020—Vanderbilt University Medical Center began vaccinating its front-line caregivers for COVID-19 on Thursday, Dec. 17.
Flu boosts pneumococcal colonization
Mar. 27, 2014—Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.
Inflammation relief: what’s the delay?
Jun. 28, 2011—New research offers hope for patients needing the anti-inflammatory benefits of glucocorticoids without the adverse side effects associated with them.